Fluoroproscaline

Fluoroproscaline (FP), also known as 4-(3-fluoropropoxy)-3,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Fluoroproscaline (FP), also known as 4-(3-fluoropropoxy)-3,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is a fluorinated derivative of proscaline. The drug has a dose range of 60 to 150 mg and a duration of 3 to 5 hours.

It is less potent than proscaline but more potent than mescaline and is much shorter-acting than proscaline or mescaline. The receptor interactions of fluoroproscaline have been studied. It is a low-affinity and low-potency agonist of the serotonin 5-HT 2A receptor.

The chemical synthesis of fluoroproscaline has been described. The drug was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of fluoroproscaline was studied in greater detail in 2021.

It is not a controlled substance in Canada as of 2025.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377026089 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.